TD Cowen Maintains Hold on Calumet, Raises Price Target to $40
Benzinga Newsdesk 2 months ago
Analyst RatingsNewsPrice Target
TD Cowen analyst Jason Gabelman maintains Calumet (NASDAQ:CLMT) with a Hold and raises the price target from $34 to $40.
TD Cowen analyst Jason Gabelman maintains Calumet (NASDAQ:CLMT) with a Hold and raises the price target from $34 to $40.